Sun Pharma receives observation from USFDA for plant in Gujarat

25 Mar 2019 Evaluate

Sun Pharmaceutical Industries has received one observation from US Food and Drug Administration (USFDA) for its Baska manufacturing facility in the state of Gujarat. The USFDA had conducted a pre-approval inspection (PAI) of Baska facility from January 28 to February 5, 2019.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.

Sun Pharma Inds. Share Price

1786.05 -40.05 (-2.19%)
10-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.05
Dr. Reddys Lab 1354.20
Cipla 1470.05
Lupin 2190.50
Zydus Lifesciences 1004.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.